6032 Federal Register / Vol. 81, No. 23 / Thursday, February 4, 2016 / Notices 

SUPPLEMENTARY INFORMATION: The 

Federal Emergency Management Agency 

(FEMA) hereby gives notice that 

pursuant to the authority vested in the 

Administrator, under Executive Order 

12148, as amended, Dolph A. Diemont, 

of FEMA is appointed to act as the 

Federal Coordinating Officer for this 

disaster. 

This action terminates the 

appointment of Thomas J. Dargan as 

Federal Coordinating Officer for this 

disaster. 

The following Catalog of Federal Domestic 

Assistance Numbers (CFDA) are to be used 

for reporting and drawing funds: 97.030, 

Community Disaster Loans; 97.031, Cora 

Brown Fund; 97.032, Crisis Counseling; 

97.033, Disaster Legal Services; 97.034, 

Disaster Unemployment Assistance (DUA); 

97.046, Fire Management Assistance Grant; 

97.048, Disaster Housing Assistance to 

Individuals and Households In Presidentially 

Declared Disaster Areas; 97.049, 

Presidentially Declared Disaster Assistance— 

Disaster Housing Operations for Individuals 

and Households; 97.050, Presidentially 

Declared Disaster Assistance to Individuals 

and Households—Other Needs; 97.036, 

Disaster Grants—Public Assistance 

(Presidentially Declared Disasters); 97.039, 

Hazard Mitigation Grant. 

W. Craig Fugate, 

Administrator, Federal Emergency 

Management Agency. 

[FR Doc. 2016–02024 Filed 2–3–16; 8:45 am] 

BILLING CODE 9111–23–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Internal Agency Docket No. FEMA–4248– 

DR; Docket ID FEMA–2016–0001] 

Mississippi; Amendment No. 2 to 

Notice of a Major Disaster Declaration 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This notice amends the notice 

of a major disaster declaration for the 

State of Mississippi (FEMA–4248–DR), 

dated January 4, 2016, and related 

determinations. 

DATES: Effective date: January 22, 2016. 

FOR FURTHER INFORMATION CONTACT: 

Dean Webster, Office of Response and 

Recovery, Federal Emergency 

Management Agency, 500 C Street SW., 

Washington, DC 20472, (202) 646–2833. 

SUPPLEMENTARY INFORMATION: The notice 

of a major disaster declaration for the 

State of Mississippi is hereby amended 

to include the following areas among 

those areas determined to have been 

adversely affected by the event declared 

a major disaster by the President in his 

declaration of January 4, 2016. 

Monroe and Prentiss Counties for 

Individual Assistance and Public Assistance. 

Panola County for Individual Assistance 

(already designated for Public Assistance). 

Clay, Itawamba, and Tallahatchie Counties 

for Public Assistance. 

The following Catalog of Federal Domestic 

Assistance Numbers (CFDA) are to be used 

for reporting and drawing funds: 97.030, 

Community Disaster Loans; 97.031, Cora 

Brown Fund; 97.032, Crisis Counseling; 

97.033, Disaster Legal Services; 97.034, 

Disaster Unemployment Assistance (DUA); 

97.046, Fire Management Assistance Grant; 

97.048, Disaster Housing Assistance to 

Individuals and Households In Presidentially 

Declared Disaster Areas; 97.049, 

Presidentially Declared Disaster Assistance— 

Disaster Housing Operations for Individuals 

and Households; 97.050, Presidentially 

Declared Disaster Assistance to Individuals 

and Households—Other Needs; 97.036, 

Disaster Grants—Public Assistance 

(Presidentially Declared Disasters); 97.039, 

Hazard Mitigation Grant. 

W. Craig Fugate, 

Administrator, Federal Emergency 

Management Agency. 

[FR Doc. 2016–02027 Filed 2–3–16; 8:45 am] 

BILLING CODE 9111–23–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Internal Agency Docket No. FEMA–4251– 

DR; Docket ID FEMA–2016–0001] 

Alabama; Major Disaster and Related 

Determinations 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This is a notice of the 

Presidential declaration of a major 

disaster for the State of Alabama 

(FEMA–4251–DR), dated January 21, 

2016, and related determinations. 

DATES: Effective Date: January 21, 2016. 

FOR FURTHER INFORMATION CONTACT: 

Dean Webster, Office of Response and 

Recovery, Federal Emergency 

Management Agency, 500 C Street SW., 

Washington, DC 20472, (202) 646–2833. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given that, in a letter dated 

January 21, 2016, the President issued a 

major disaster declaration under the 

authority of the Robert T. Stafford 

Disaster Relief and Emergency 

Assistance Act, 42 U.S.C. 5121 et seq. 

(the ‘‘Stafford Act’’), as follows: 

I have determined that the damage in 

certain areas of the State of Alabama 

resulting from severe storms, tornadoes, 

straight-line winds, and flooding during the 

period of December 23–31, 2015, is of 

sufficient severity and magnitude to warrant 

a major disaster declaration under the Robert 

T. Stafford Disaster Relief and Emergency 

Assistance Act, 42 U.S.C. 5121 et seq. (the 

‘‘Stafford Act’’). Therefore, I declare that such 

a major disaster exists in the State of 

Alabama. 

In order to provide Federal assistance, you 

are hereby authorized to allocate from funds 

available for these purposes such amounts as 

you find necessary for Federal disaster 

assistance and administrative expenses. 

You are authorized to provide Public 

Assistance in the designated areas and 

Hazard Mitigation throughout the State. 

Consistent with the requirement that Federal 

assistance be supplemental, any Federal 

funds provided under the Stafford Act for 

Hazard Mitigation will be limited to 75 

percent of the total eligible costs. Federal 

funds provided under the Stafford Act for 

Public Assistance also will be limited to 75 

percent of the total eligible costs, with the 

exception of projects that meet the eligibility 

criteria for a higher Federal cost-sharing 

percentage under the Public Assistance 

Alternative Procedures Pilot Program for 

Debris Removal implemented pursuant to 

section 428 of the Stafford Act. 

Further, you are authorized to make 

changes to this declaration for the approved 

assistance to the extent allowable under the 

Stafford Act. 

The Federal Emergency Management 

Agency (FEMA) hereby gives notice that 

pursuant to the authority vested in the 

Administrator, under Executive Order 

12148, as amended, Elizabeth Turner, of 

FEMA is appointed to act as the Federal 

Coordinating Officer for this major 

disaster. 

The following areas of the State of 

Alabama have been designated as 

adversely affected by this major disaster: 

Autauga, Barbour, Blount, Bullock, Butler, 

Chambers, Cherokee, Clay, Cleburne, Coffee, 

Colbert, Conecuh, Covington, Crenshaw, 

Cullman, Dale, DeKalb, Elmore, Escambia, 

Fayette, Franklin, Geneva, Henry, Houston, 

Jackson, Lamar, Lawrence, Lee, Lowndes, 

Macon, Marion, Marshall, Monroe, Perry, 

Pike, Russell, St. Clair, Walker, and Winston 

Counties for Public Assistance. 

All areas within the State of Alabama are 

eligible for assistance under the Hazard 

Mitigation Grant Program. 

The following Catalog of Federal Domestic 

Assistance Numbers (CFDA) are to be used 

for reporting and drawing funds: 97.030, 

Community Disaster Loans; 97.031, Cora 

Brown Fund; 97.032, Crisis Counseling; 

97.033, Disaster Legal Services; 97.034, 

Disaster Unemployment Assistance (DUA); 

97.046, Fire Management Assistance Grant; 

97.048, Disaster Housing Assistance to 

Individuals and Households In Presidentially 

Declared Disaster Areas; 97.049, 

Presidentially Declared Disaster Assistance— 

Disaster Housing Operations for Individuals 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 23 / Thursday, February 4, 2016 / Notices 6033 

and Households; 97.050, Presidentially 

Declared Disaster Assistance to Individuals 

and Households—Other Needs; 97.036, 

Disaster Grants—Public Assistance 

(Presidentially Declared Disasters); 97.039, 

Hazard Mitigation Grant. 

W. Craig Fugate, 

Administrator, Federal Emergency 

Management Agency. 

[FR Doc. 2016–02021 Filed 2–3–16; 8:45 am] 

BILLING CODE 9111–23–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2016–0010] 

Cooperative Research and 

Development Agreement Opportunity 

With the Department of Homeland 

Security for the International Foot-andMouth Disease Vaccine and 

Diagnostics Field Trial 

AGENCY: Chemical and Biological 

Defense Division (CBD), Homeland 

Security Advanced Research Projects 

Agency, Science and Technology 

Directorate, Department of Homeland 

Security. 

ACTION: Notice of intent. 

SUMMARY: The Department of Homeland 

Security (DHS), Science and Technology 

Directorate (S&T), through its Homeland 

Security Advanced Research Projects 

Agency (HSARPA), Chemical Biological 

Defense Division (CBD) is implementing 

and executing an international foot-andmouth disease (FMD) vaccine and 

diagnostics field trial. The objective of 

the project is to evaluate a newly 

developed FMD vaccine(s) and 

companion diagnostic(s) in an FMDV 

endemic country. The specific goals of 

this project are to establish the efficacy 

of the newly developed replicationdeficient adenovirus-vectored FMD 

(AdFMD) vaccine; the effectiveness, 

sensitivity, specificity, and ruggedness 

of a new companion diagnostic test (‘‘3B 

ELISA’’) under field conditions, and to 

provide data on the usage of a DIVA 

vaccine and companion diagnostic in an 

endemic disease situation which may be 

used to inform the U.S. response to an 

FMD outbreak. DHS anticipates that this 

project may lead to the development 

and fostering of partnerships and 

collaborations with industry, countries 

and national and international 

organizations that will result in a solid 

foundation that will facilitate the future 

development and testing of additional 

transboundary animal disease (TAD) 

vaccines and diagnostics. 

CBD is seeking industry partners to 

enter into a Cooperative Research and 

Development Agreement (CRADA). It is 

envisioned that the primary role of the 

selected industry collaborator(s) will be 

to provide subject matter experts to 

inform the vaccine and diagnostic field 

trial design(s), country selection and 

regulatory processes, in addition to 

potentially developing, manufacturing 

and distributing or providing, the 

AdFMD experimental vaccines and 

companion ELISA diagnostic kits for the 

field trial. 

DATES: Submit comments on or before 

March 7, 2016. 

ADDRESSES: Mail comments and 

requests to participate to Dr. Roxann 

Motroni, (ATTN: Roxann Motroni, 245 

Murray Lane SW., Washington, DC 

20528–0075). Submit electronic 

comments and other data with the 

subject line ‘‘International FMD Field 

Trial Notice of Intent’’ to 

Roxann.Motroni@hq.dhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Information on DHS CRADAs: Scott 

Pugh, scott.pugh@hq.dhs.gov, (202) 

254–2288. 

SUPPLEMENTARY INFORMATION: 

Background 

Ensuring livestock resiliency across 

the United States is crucial to the 

economic success of the American 

livestock industry. Foot-and-mouth 

disease (FMD) is caused by a highly 

infectious virus that affects clovenhoofed animals and causes high 

morbidity. While the animal health 

consequences are serious, the economic 

consequences are grave, since all trade 

of animals and animal products from 

the U.S. will cease. Worldwide, FMD 

eradication and control is difficult as it 

is costly, requires significant animal 

health infrastructure, and infection or 

vaccination with a single strain of a 

serotype often does not confer 

protection against other strains of the 

virus. 

Many countries with periodic FMD 

outbreaks vaccinate with a ‘‘killed’’ 

vaccine produced by inactivating the 

FMD virus (FMDV) and adding an 

immune system stimulant called an 

adjuvant. The killed vaccine has several 

drawbacks, including the requirement 

for high biosecurity production facilities 

to reduce the risk of accidental release 

of live FMDV, and the need for costly, 

sophisticated, and consistent 

purification procedures to remove 

FMDV pieces that may cause animals 

vaccinated with the killed FMD vaccine 

to test FMD positive in 3B based 

diagnostic assays. 

Because killed FMD vaccines vary in 

their ability to consistently differentiate 

infected from vaccinated animals 

(DIVA), under current regulations, 

killed FMD vaccine usage in an 

outbreak could result unnecessarily in 

the humane euthanasia of both 

vaccinated and infected animals. 

The Department of Homeland 

Security, and United States Department 

of Agriculture (USDA) scientists at Plum 

Island Animal Disease Center, working 

with industry partners have developed 

an effective AdFMD vaccine that does 

not required live FMDV for 

manufacturing and is also DIVA 

compatible, giving the U.S. a key 

component of implementing a 

vaccinate-to-live policy. In 2012, DHS 

S&T successfully pursued licensure for 

a single FMD serotype, A24 Cruzeiro, 

however this single vaccine will not 

protect against the multitude of other 

FMD serotypes/subtypes/topotypes that 

exist, thus DHS S&T has interest in 

continued development of additional 

serotype and broader spectrum 

vaccines. Since FMD is not endemic to 

the U.S., the goals of the International 

FMD Vaccine and Diagnostic Field Trial 

are to test the efficacy of these newly 

developed vaccines, and the DIVA 

compatibility of the vaccines using one 

or more companion ELISA diagnostic 

tests under natural exposure conditions. 

Role of the Industry Collaborator 

Any selected industry collaborator 

would play a crucial role in the CRADA 

partnership to implement and execute 

the international FMD vaccine field 

trial. Each proposal must address item 

1, and may address one or more of items 

2–6: 

1. Provide subject matter expertise for 

vaccine and companion ELISA 

diagnostic trial design, data analysis, 

country selection, and import and 

export regulations for biological 

products, be they licensed or 

experimental; 

2. Manufacture, test, and release FMD 

vaccines (experimental AdFMD and/or 

currently licensed, killed vaccines) and 

companion ELISA diagnostic kits to be 

used in field trial; 

3. Acquisition, transport, export, and 

import of the experimental and killed 

conventional vaccines, and companion 

ELISA diagnostic kits into the FMD 

endemic country; 

4. Research and development 

capabilities to construct AdFMD 

vaccine candidates and/or produce premaster seed AdFMD viruses for 

additional FMD serotypes/topotypes/

lineages for which new vaccines may be 

required; 

5. Real-time data analysis for the 

AdFMD field trial as the trial is 

conducted; and 


asabaliauskas on DSK5VPTVN1PROD with NOTICES